Track Viatris Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Viatris Inc. VTRS · Stock Open Viatris Inc. in new tab

20.82 USD
EPS
-0.53
Yield
2.51%
Safety Score
53
P/B
1.74
ROE
-4.21
Beta
0.87
Target Price
21.30 USD
Viatris Inc. logo

Viatris Inc.

🧾 Earnings Recap – Q3 2026

Viatris shares fell 1.3% after earnings, a roughly flat reaction. The quarter showed growth and the company raised guidance midpoints, while the announced Pacira acquisition and several pipeline programs remain execution-dependent.

  • Q3 revenue was $3.75 billion, adjusted EBITDA was $1.2 billion, and adjusted EPS was $0.71.
  • For the first nine months, revenue grew 2%, adjusted EBITDA 6%, and adjusted EPS 8% operationally year over year.
  • Viatris narrowed its 2026 guidance ranges and raised the midpoint for all key financial metrics, citing performance and expected fourth-quarter momentum.
  • North America and Greater China were growth areas; management pointed to estradiol patches and injectable launches in North America, and cardiovascular products and established brands in China.
  • The proposed Pacira acquisition would add EXPAREL and ZILRETTA and, if completed, is expected to take U.S. innovative medicines revenue above $1 billion in 2027.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 25, 2027
EPS-0.53
Book Value11.94
Price to Book1.74
Debt/Equity99.22
% Insiders0.517%
Growth
Revenue Growth0.00%
Earnings Growth-0.52%
Estimates
Forward P/E7.59
Forward EPS2.74
Target Mean Price21.30
Dividend
Dividend Yield2.51%
Annual dividends0.48 USD
Ex-Div. DateNov. 23, 2026
Payout-91.33%
5y avg Yield0.89%

DCF valuation

Model fair value for Viatris Inc. (VTRS)
Result
Sign in to run the valuation for VTRS.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
10 analysts · consensus Buy · mean target 21.30 USD (low 14.00, high 28.00) · as of 15 Nov 2026
Low 14.00
Mean 21.30
High 28.00
Price 20.82
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Viatris Inc. Logo Viatris Inc. Analysis (VTRS)

United States Health Care Official Website Stock

Is Viatris Inc. a good investment? Viatris Inc. (VTRS) is currently trading at 20.82 USD. Market analysts have a consensus price target of 21.30 USD. This suggests a potential upside from current levels.

Earnings Schedule: Viatris Inc. is expected to release its next earnings report on Feb. 25, 2027. The market consensus estimate for Forward EPS is 2.74.

For income investors, Viatris Inc. pays a dividend yield of 2.51%. With a payout ratio of -91%, the dividend appears sustainable.

Investor FAQ

Does Viatris Inc. pay a dividend?

Yes, it pays an annual dividend of 0.48 USD (2.51% yield).

What asset class is Viatris Inc.?

Viatris Inc. is classified as a Stock. You can compare it against 11 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 25, 2027. The company currently has a trailing EPS of -0.53.

Company Profile

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Exchange Ticker
BER (Germany) VIA.BE
GER (Germany) VIA.DE
DUS (Germany) VIA.DU
FRA (Germany) VIA.F
HAM (Germany) VIA.HM
IOB (United Kingdom) 0A5V.IL
MIL (Italy) VIA.MI
MUN (Germany) VIA.MU
MEX (Mexico) VTRS.MX
VIE (Austria) VTRS.VI
NMS (United States) VTRS
Trades
Dividend Yield
2.51%
5y avg 0.89%
Annual Dividends
0.48USD
Next Ex. Div Date
Nov. 23, 2026
Payout Ratio
-91.33%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2027
0.37 USD
Sept. 16, 2027 (estimated) 0.1236
June 16, 2027 (estimated) 0.1236
March 18, 2027 (estimated) 0.1200
▸2026
0.48 USD
Dec. 16, 2026 0.1200
Sept. 16, 2026 0.1200
June 17, 2026 0.1200
March 18, 2026 0.1200
▸2025
0.48 USD
Dec. 15, 2025 0.1200
Sept. 15, 2025 0.1200
June 16, 2025 0.1200
March 18, 2025 0.1200
▸2024
0.48 USD
Dec. 13, 2024 0.1200
Sept. 13, 2024 0.1200
June 14, 2024 0.1200
March 18, 2024 0.1200
▸2023
0.48 USD
Dec. 15, 2023 0.1200
Sept. 15, 2023 0.1200
June 16, 2023 0.1200
March 17, 2023 0.1200
▸2022
0.48 USD
Dec. 16, 2022 0.1200
Sept. 16, 2022 0.1200
June 16, 2022 0.1200
March 16, 2022 0.1200
▸2021
0.33 USD
Dec. 16, 2021 0.1100
Sept. 16, 2021 0.1100
June 16, 2021 0.1100
▸2007
0.18 USD
July 16, 2007 0.0600
April 16, 2007 0.0600
Jan. 16, 2007 0.0600
▸2006
0.24 USD
Oct. 16, 2006 0.0600
July 14, 2006 0.0600
April 17, 2006 0.0600
Jan. 13, 2006 0.0600
▸2005
0.18 USD
Oct. 17, 2005 0.0600
July 15, 2005 0.0600
April 15, 2005 0.0300
Jan. 14, 2005 0.0300
▸2004
0.12 USD
Oct. 15, 2004 0.0300
July 15, 2004 0.0300
April 15, 2004 0.0300
Jan. 15, 2004 0.0300
▸2003
0.15 USD
Oct. 15, 2003 0.0333
July 15, 2003 0.0333
April 15, 2003 0.0333
Jan. 15, 2003 0.0500
▸2002
0.16 USD
Oct. 15, 2002 0.0400
July 15, 2002 0.0400
April 15, 2002 0.0400
Jan. 15, 2002 0.0400
▸2001
0.16 USD
Oct. 15, 2001 0.0400
July 16, 2001 0.0400
April 16, 2001 0.0400
Jan. 15, 2001 0.0400
▸2000
0.16 USD
Oct. 15, 2000 0.0400
July 14, 2000 0.0400
April 15, 2000 0.0400
Jan. 14, 2000 0.0400
▸1999
0.16 USD
Oct. 15, 1999 0.0400
July 15, 1999 0.0400
April 15, 1999 0.0400
Jan. 15, 1999 0.0400
▸1998
0.16 USD
Oct. 15, 1998 0.0400
July 15, 1998 0.0400
April 15, 1998 0.0400
Jan. 15, 1998 0.0400
▸1997
0.16 USD
Oct. 15, 1997 0.0400
July 15, 1997 0.0400
April 15, 1997 0.0400
Jan. 15, 1997 0.0400
▸1996
0.16 USD
Oct. 15, 1996 0.0400
July 15, 1996 0.0400
April 15, 1996 0.0400
Jan. 15, 1996 0.0400
▸1995
0.14 USD
Oct. 13, 1995 0.0400
July 14, 1995 0.0500
April 13, 1995 0.0500
▸1994
0.19 USD
Dec. 23, 1994 0.0600
Sept. 26, 1994 0.0500
June 24, 1994 0.0400
March 25, 1994 0.0400
▸1993
0.14 USD
Dec. 27, 1993 0.0400
Sept. 24, 1993 0.0400
June 24, 1993 0.0300
March 25, 1993 0.0300
▸1992
0.16 USD
Dec. 24, 1992 0.0300
Sept. 24, 1992 0.0300
June 24, 1992 0.0500
March 25, 1992 0.0500
▸1991
0.20 USD
Dec. 24, 1991 0.0500
Sept. 24, 1991 0.0500
June 24, 1991 0.0500
March 22, 1991 0.0500
▸1990
0.20 USD
Dec. 24, 1990 0.0500
Oct. 15, 1990 0.0500
July 16, 1990 0.0500
Jan. 15, 1990 0.0500
▸1989
0.08 USD
July 17, 1989 0.0500
Jan. 16, 1989 0.0250
▸1988
0.10 USD
July 15, 1988 0.0500
Jan. 15, 1988 0.0500
▸1987
0.10 USD
July 15, 1987 0.0500
Jan. 15, 1987 0.0500
Upcoming Dividends
Name Payment Date Status Amount
Viatris Inc. Dec 16, 2026 Upcoming 0.12 USD
Viatris Inc. Sep 16, 2026 0.12 USD
Viatris Inc. Jun 17, 2026 0.12 USD
Viatris Inc. Mar 18, 2026 0.12 USD
Viatris Inc. Dec 15, 2025 0.12 USD
Stock Splits
Split Date Split Ratio to 1
Nov. 16, 1981 2:1
July 1, 1983 2:1
March 2, 1984 1.5
Aug. 1, 1984 1.5
Feb. 19, 1985 2:1
Aug. 4, 1986 1.5
Aug. 3, 1992 2:1
Aug. 16, 1995 1.5
Jan. 28, 2003 1.5
Oct. 9, 2003 1.5
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion